BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

NERLYNX® Approved in Thailand for Early and Advanced HER2+ Breast Cancer Treatment

NERLYNX® (neratinib) has been approved as a single agent for the treatment of early-stage HER2+ breast cancer, and in combination with capecitab...

February 18, 2025 | News

Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...

February 17, 2025 | News

PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies

PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop pr...

February 12, 2025 | News

Pfizer and Astellas Announce Sustained Survival Benefit in Advanced Urothelial Cancer with PADCEV® and KEYTRUDA® Combination

Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination a...

February 11, 2025 | News

LG AI Research Partners with Seoul National University to Advance Protein Multistate Prediction AI

LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, Seoul, with Prof. Min-Kyung Baek&n...

February 10, 2025 | News

Thermo Fisher Scientific Launches CorEvitas Adolescent Alopecia Areata Registry to Advance Real-World Research

Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Reg...

February 06, 2025 | News

Nuvation Bio Launches Expanded Access Program in the U.S. for Taletrectinib in ROS1+ NSCLC

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced it has initiated ...

February 04, 2025 | News

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...

January 30, 2025 | News

Australia’s Inventia Life Science Launches RASTRUM™ Allegro to Transform 3D Cell Culture Research

Inventia Life Science has announced the release of RASTRUM™ Allegro, a new development in 3D cell culture technology aimed at addressing challenges i...

January 28, 2025 | News

ThinkCyte Expands Product Line to Advance Drug Discovery and Disease Research Innovation

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will ...

January 28, 2025 | News

Azenta Life Sciences Powers UK Biocentre's Expansion with BioArc Ultra™ for Large-Scale Sample Storage

Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample st...

January 27, 2025 | News

Novilytic Joins Forces with Avantor to Transform Drug Discovery with Proteometer® Platform

Novilytic, an innovator in molecular recognition technology, is proud to announce an exclusive distribution partnership with Avantor, a global supplier o...

January 23, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Stay Connected